Triethyllead-induced hypomyelination in the developing rat forebrain.
D000818:Animals; D000831:Animals, Newborn; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000254:growth & development*; D001923:Brain Chemistry; D002554:Cerebrosides / Q000032:analysis; D002784:Cholesterol / Q000032:analysis; D006017:Glycolipids / Q000032:analysis; D007854:Lead / Q000494:pharmacology; D007855:Lead Poisoning / Q000503:physiopathology*; D008055:Lipids / Q000032:analysis*; D009186:Myelin Sheath / Q000187:drug effects*; D009929:Organ Size; D009942:Organometallic Compounds / Q000494:pharmacology; D010743:Phospholipids / Q000032:analysis; D051381:Rats; D013433:Sulfoglycosphingolipids / Q000032:analysis
D002554:Cerebrosides; D006017:Glycolipids; D008055:Lipids; D009942:Organometallic Compounds; D010743:Phospholipids; D013433:Sulfoglycosphingolipids; D007854:Lead; C010360:triethyllead; D002784:Cholesterol